Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000974739 | SCV001122592 | benign | Sphingolipid activator protein 1 deficiency | 2025-01-19 | criteria provided, single submitter | clinical testing | |
ARUP Laboratories, |
RCV003736945 | SCV004562250 | likely benign | not provided | 2023-09-18 | criteria provided, single submitter | clinical testing | |
Breakthrough Genomics, |
RCV003736945 | SCV005321863 | benign | not provided | criteria provided, single submitter | not provided | ||
Natera, |
RCV001272682 | SCV001454921 | likely benign | Metachromatic leukodystrophy | 2020-04-11 | no assertion criteria provided | clinical testing | |
Prevention |
RCV003918568 | SCV004744951 | likely benign | PSAP-related disorder | 2021-01-19 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |